Offer - Urjas Oil for just ₹ 1 X
Pegheal is a prescription medicine. It is primarily used for the treatment of Neutropenia.
Medical history of the patient along with age and gender determines the dosage of Pegheal. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Pegheal side effects, there are can be others also. These have been listed below. Normally, these side effects of Pegheal are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Pegheal is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Pegheal's effects on the liver, heart and kidney are discussed below in the Pegheal related warnings section.
Pegheal can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pegheal in conditions like Blood Cancer. Other conditions have been mentioned below in the Pegheal contraindications section.
Drug reaction of Pegheal with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Pegheal is considered safe while driving, and is addictive.
Pegheal is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Pegheal safe for pregnant women?
Pegheal may have some side effects during pregnancy. Pregnant women should discontinue the use of Pegheal, and talk to their doctor, if they notice any discomfort.
Is the use of Pegheal safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Pegheal. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Pegheal on the Kidneys?
Pegheal rarely harms the kidneys.
What is the effect of Pegheal on the Liver?
Pegheal is rarely harmful for the liver.
What is the effect of Pegheal on the Heart?
The heart can be affected by Pegheal. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Pegheal should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pegheal unless your doctor advises you to do so -
Is this Pegheal habit forming or addictive?
Forming a habit of Pegheal has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Pegheal will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Pegheal is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Pegheal for mental disorders.
Interaction between Food and Pegheal
There isn't any research available on the side effects of taking Pegheal with food.
Interaction between Alcohol and Pegheal
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Pegheal.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560